Asset Details
Do you wish to reserve the book?
Low Tissue Plasminogen Activator Relative to Plasminogen Activator Inhibitor-1 as a Marker of Cardiac Complication in Children With Kawasaki Disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Low Tissue Plasminogen Activator Relative to Plasminogen Activator Inhibitor-1 as a Marker of Cardiac Complication in Children With Kawasaki Disease
Do you wish to request the book?
Low Tissue Plasminogen Activator Relative to Plasminogen Activator Inhibitor-1 as a Marker of Cardiac Complication in Children With Kawasaki Disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Low Tissue Plasminogen Activator Relative to Plasminogen Activator Inhibitor-1 as a Marker of Cardiac Complication in Children With Kawasaki Disease
2001
Overview
To determine whether the fibrinolytic system is related to the occurrence of cardiac complication in Kawasaki disease, we measured tissue plasminogen activator, plasminogen activator inhibitor-1, and related factors in the plasma of children with Kawasaki disease. Patients (mean age, 1.8 years) were classified into patients with cardiac complication (n = 9) and no complication (n = 14) groups echocardiographically. They underwent single, high-dose, intravenous γ-globulin infusion therapy. Blood was drawn just before and the day after the single high-dose intravenous γ-globulin infusion therapy (acute phase), and at early and late convalescent phases. Leukocytosis was normalized immediately after the single, high-dose, intravenous γ-globulin infusion therapy. C-reactive protein and fibrinogen were increased in the acute phase and normalized by convalescent phases. D-dimer fraction of fibrin degradation products changed in a similar manner. Tissue plasminogen activator and plasminogen activator inhibitor-1 were increased in acute phase. The tissue plasminogen activator/plasminogen activator inhibitor-1 ratio was lower in the complication group than in the no complication group throughout the observation period (0.095 versus 0.208 after single, high-dose, intravenous γ-globulin infusion therapy, p = 0.006; 0.094 versus 0.183 at late convalescent phase, p = 0.024). A low tissue plasminogen activator/plasminogen activator inhibitor-1 ratio can predict the propensity for cardiac complication, and can help the physician to decide whether additional therapies are necessary in acute phase Kawasaki disease.
Publisher
SAGE Publications,SAGE PUBLICATIONS, INC
Subject
/ Bats
/ C-Reactive Protein - analysis
/ Female
/ Fibrin Fibrinogen Degradation Products - analysis
/ Heart Diseases - diagnostic imaging
/ Humans
/ Immunoglobulins, Intravenous - therapeutic use
/ Infant
/ Male
/ Mucocutaneous Lymph Node Syndrome - blood
/ Mucocutaneous Lymph Node Syndrome - complications
/ Mucocutaneous Lymph Node Syndrome - therapy
/ Plasminogen Activator Inhibitor 1 - analysis
